学术论文: |
发表文章(近三年,10篇以内) [1]Wang Y#, Xu C#, Meng M, Lin L, Hu Y, Hao K, Sheng S, Zhang S, Wu J, Liu F, Jiang X, Tian H, Chen X. Precise Regulation of Inflammation and Immunosuppressive Microenvironment for Amplified Photothermal/immunotherapy against Tumour Recurrence and Metastasis. Nano Today, 2021, 40, 101266. [2]Xu C, Wang Y, Wang E, Yan N, Sheng S, Chen J, Lin L, Guo Z, Tian H*, Chen X. Effective Eradication of Tumors by Enhancing Photoacoustic-Imaging-Guided Combined Photothermal Therapy and Ultrasonic Therapy. Advanced Functional Materials, 2021, 31, 2009314. [3]Zhang X, Si Z, Wang Y, Li Y*, Xu C*, Tian H*. Polymerization and Coordination Synergistically Constructed Photothermal Agents for Macrophages-mediated Tumor Targeting Diagnosis and Therapy. Biomaterials, 2021, 264. [4]Sheng S, Liu F, Lin L, Yan N, Wang Y, Xu C*, Tian H*, Chen X. Nanozyme-mediated Cascade Reaction Based on Metal-Organic Framework for Synergetic Chemo-Photodynamic Tumor Therapy. Journal of Controlled Release 2020;328: 631-9. [5]Liu F, Lin L, Zhang Y, Sheng S, Wang Y, Xu C*, Tian H*, Chen X. Two-Dimensional Nanosheets with High Curcumin Loading Content for Multimodal Imaging-Guided Combined Chemo-Photothermal Therapy. Biomaterials, 2019, 223. [6]Yan N, Lin L, Xu C*, Tian H*, Chen X. A GSH-Gated DNA Nanodevice for Tumor-Specific Signal Amplification of microRNA and MR Imaging-Guided Theranostics. Small, 2019, 15. [7]Xu C, Wang Y, Guo Z, Chen J, Lin L, Wu J, Tian H*, Chen X. Pulmonary Delivery by Exploiting Doxorubicin and Cisplatin co-loaded Nanoparticles for Metastatic Lung Cancer Therapy. Journal of Controlled Release 2019, 295, 153. [8]Wang Y, Liu F, Yan N, Sheng S, Xu C*, Tian H*, et al. Exploration of Fe-III-Phenol Complexes for Photothermal Therapy and Photoacoustic Imaging. Acs Biomaterials Science & Engineering 2019; 5: 4700. Xue T#, Xu C#, Wang Y, Wang Y, Tian H, Zhang Y*. Doxorubicin-loaded nanoscale metal-organic framework for tumor-targeting combined chemotherapy and chemodynamic therapy. Biomaterials Science 2019; 7: 4615-23. |